Anavex Life Sciences Corp (AVXL)

[falconer66a]

Obfuscation, clearly.

We don't "own it..."

You're making that up, for whatever reason. Anavex Life Sciences does own blarcamesine, in every respect.

And, please post any data from other sigma-1 receptor agonists that even approximate those of blarcamesine. Sure, there are other molecules that attach to, are sigma-1 receptor ligands. But not a one has either the safety record of blarcamesine, or the profound, multiple disease moderation successes.

No competition.

Then, could you provide some guidance when any or all of those "other" sigma-1 receptor agonists might hit the market, be allowed to be sold? Will that be before or after blarcamesine is approved by the FDA or TGA? For what diseases? Give us a timeline, please. (Or, is all of that also conveniently nebulous and hazy?)